Clinical Trials Logo

Obesity, Morbid clinical trials

View clinical trials related to Obesity, Morbid.

Filter by:

NCT ID: NCT03279653 Recruiting - Obesity, Morbid Clinical Trials

Pancreatic Exocrine Insufficiency After Bariatric Surgery

Start date: September 1, 2017
Phase: N/A
Study type: Observational

Main proposed benefit of sleeve gastrectomy is loss of ghrelin secreting tissue. Some studies express that ghrelin augment pancreatic regeneration. Therefore we hypothesized that with sleeve gastrectomy it may result with pancreatic insufficiency.

NCT ID: NCT03273855 Enrolling by invitation - Obesity, Morbid Clinical Trials

Randomized Controlled Trial of Fecal Microbiota Transplantation in Severe Obesity

RCTFMTOb
Start date: May 13, 2019
Phase: N/A
Study type: Interventional

This is a randomized, double-blinded and placebo controlled prospective trial with sixty patients to investigate the effect of fecal microbiota transplantation (FMT) on body weight in patients with severe obesity. We will also collect data that possibly could give a better understanding of mechanisms of this correlation.

NCT ID: NCT03269968 Terminated - Obesity, Morbid Clinical Trials

Use of Negative Pressure Wound Therapy in Morbidly Obese Women After Cesarean Delivery

Start date: October 3, 2017
Phase: N/A
Study type: Interventional

Obese women are more likely have a cesarean delivery and develop subsequent wound complications than normal weight women. Negative pressure wound therapy (NPWT) has been shown to improve surgical wound healing, but this device has not been adequately studied in cesarean deliveries. The aim of our study is to determine the efficacy of NPWT in morbidly obese women after cesarean delivery. Investigators will be randomizing women with a BMI > 40 kg/m2 in a 1:1 ratio to either NPWT (the PREVENA Incision management therapy system Pre 1001 Us) or standard dressing after their cesarean delivery at MedStar Washington Hospital Center. The NPWT will be left in place for a minimum of four days but not to exceed seven days. The standard dressing is typically removed on postoperative day one or two. The primary outcome is a wound complication defined as the formation of a wound infection, seroma, hematoma, separation, or dehiscence from delivery to 4 weeks postpartum. Investigators will also administer a patient satisfaction survey regarding their wound healing experience.

NCT ID: NCT03263390 Terminated - Obesity, Morbid Clinical Trials

Modeling the Neurological Basis and Characterizing the Neurological Phenotype of Obesity Using Human Neural Stem Cells

Start date: October 5, 2017
Phase:
Study type: Observational

This study aims to characterize the neurological basis of obesity and response to surgical and medical treatment by inducing adult pluripotent stem cells into neuronal cells from subjects that have demonstrated extreme response to bariatric surgery or pharmacological treatment for obesity.

NCT ID: NCT03249441 Active, not recruiting - Severe Obesity Clinical Trials

Compassion-Focused Therapy for People With Severe Obesity.

CFT
Start date: September 15, 2016
Phase: N/A
Study type: Interventional

This study aims to explore the effectiveness of a group psychotherapy intervention using Compassion-Focused Therapy (CFT) in adults with severe obesity. In particular, it aims to evaluate the principle that CFT can be used to reduce levels of shame and self-criticism in adults with severe obesity OBJECTIVES: The objective of the current study is to assess and compare a CFT group intervention to Treatment as Usual (TAU) with regard to psychological functioning, specifically self-compassion, shame, self-criticism, emotional eating and mood.

NCT ID: NCT03246672 Completed - Obesity, Morbid Clinical Trials

Development of a Weight Maintenance Intervention for Bariatric Surgery Patients

MAINTAIN-B
Start date: January 3, 2018
Phase: N/A
Study type: Interventional

Although bariatric surgery is highly effective for inducing significant weight loss and resolution of comorbidities, weight regain following surgery is a common problem. This pilot study will test the feasibility and acceptability of an intervention designed to help bariatric surgery patients maintain weight loss. Findings from this pilot will provide the foundation for a randomized controlled trial to evaluate the efficacy of the intervention.

NCT ID: NCT03246386 Completed - Morbid Obesity Clinical Trials

Dosing Obese With Noxafil® Under a Trial (DONUT)

DONUT
Start date: November 5, 2017
Phase: Phase 4
Study type: Interventional

Although posaconazole is approved for the prophylaxes and treatment of invasive fungal infections, specific dosing guidelines for posaconazole in (morbidly) obese patients are not specified. There is clear evidence indicating that heavier patients are receiving a sub-optimal dose if the current guidelines are used. Specifically in the setting of augmented prevalence of species with intermediate susceptible to posaconazole, adequate dosing is needed at start of treatment. Therefore it seems prudent to conduct a trial in a cohort of obese patients who receive posaconazole (300mg or 400mg) and define the pharmacokinetics. These will then be compared to the pharmacokinetics in a normal-weight group receiving 300mg posaconazole.

NCT ID: NCT03240367 Completed - Obesity, Morbid Clinical Trials

Comparison of Stapler Line Bleeding Control Techniquessurgery

Start date: December 4, 2016
Phase: N/A
Study type: Interventional

Introduction RYGB surgeon; Have become increasingly morbid obesity treatment methods with improvements in minimally invasive surgery. Ensuring patient comfort and early return to life are the criteria that should be given priority in this treatment method.The purpose of this study; Emphasizing that the cautery technique of the stapler line bleeding control methods is as successful as the other methods.

NCT ID: NCT03231423 Completed - Obesity, Morbid Clinical Trials

Effect of Drainage on Laparoscopic Gastric Bypass Surgery

Start date: December 9, 2016
Phase: N/A
Study type: Interventional

Introduction RYGB surgeon; Have become increasingly morbid obesity treatment methods with improvements in minimally invasive surgery. Ensuring patient comfort and early return to life are the criteria that should be given priority in this treatment method. The purpose of this study is to determine the use of drain, which closely affects these criteria; And the effect on patient comfort.

NCT ID: NCT03222414 Terminated - Blood Pressure Clinical Trials

Non-invasive Versus Invasive Blood Pressure Measurement in the Morbidly Obese Parturient With Severe Preeclampsia

Start date: May 1, 2015
Phase: N/A
Study type: Interventional

The study will compare agreement of invasive blood pressure measurements with non-invasive blood pressure measurements measured with a conical blood pressure and large standard upper arm rectangular cuff in morbidly obese severely hypertensive (systolic blood pressure > 160 mmHg) parturients.